Principal Financial Group
IMNM icon

Principal Financial Group’s Immunome IMNM Stock Holding History

Principal Financial Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.6M Sell
1,347,358
-29,509
-2% -$631K 0.01% 785
2026
Q1 		$30.1M Sell
1,376,867
-27,583
-2% -$614K 0.02% 687
2025
Q4 		$30.2M Buy
1,404,450
+299,512
+27% +$5.26M 0.02% 660
2025
Q3 		$12.9M Buy
1,104,938
+762,147
+222% +$7.58M 0.01% 1136
2025
Q2 		$3.19M Buy
+342,791
New +$2.81M ﹤0.01% 1707

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Principal Financial Group's IMNM Position: Q2 2026 in Review

Principal Financial Group reduced its Immunome (IMNM) stake by 2.1% in Q2 2026, selling an estimated $631K and leaving 1,347,358 shares worth $28.6M. The position accounts for 0.01% of the portfolio, ranked #785.

Principal Financial Group first reported a position in IMNM in Q2 2025 and has held it in 5 quarters since. The position peaked at $30.2M in Q4 2025. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Principal Financial Group held 1,347,358 shares of Immunome worth $28.6M as of Q2 2026.
  • Principal Financial Group sold 29,509 Immunome shares in Q2 2026, an estimated $631K.
  • Immunome made up 0.01% of Principal Financial Group's portfolio in Q2 2026, its #785 holding.
  • Principal Financial Group first reported a position in Immunome in Q2 2025 and has held it in 5 quarters since.
  • Principal Financial Group's Immunome position peaked at $30.2M in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.